US Patent 11154563 Immunoproteasome inhibitors
Patent 11154563 was granted and assigned to Principia Biopharma Inc. on October, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 16, 2018
Date of Patent
October 26, 2021
Patent Applicant
Patent Application Number
20180116
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11154563 Immunoproteasome inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
